FUTURE Biobank

Research Technology centers Radboud biobank News Biobank FUTURE Biobank

3 December 2019

The FUTURE biobank consists of residual biomaterial (serum and plasma) from the FUTURE study. The “Follow-Up of Transient ischemic attack and stroke patients and Unelucidated Risk factor Evaluation” (FUTURE) study is a prospective cohort study of prognosis of stroke in young adults. This study comprised patients aged 18 through 50 years with a TIA, ischemic stroke or intracerebral hemorrhage (1980-2010). The associated clinical data consists of baseline and clinical characteristics, including demographic data, stroke subtype and vascular risk factors.

Want to know more about these subjects? Click on the buttons below for more news.

Radboud Biobank

Related news items

TETRO-trial

30 March 2023

The TETRO-trial is a study on a new treatment for compulsive/obsessive-compulsive disorder.

Archipelago

30 March 2023

Archipelago of Ovarian Cancer Research (AOCR) is a national platform for centralizing and expanding scientific research into ovarian cancer.

EVA-trial

30 March 2023

The Department of Obstetrics and Gynecology established the EVA trial biobank with the aim of enabling scientific research into high blood pressure in pregnancy.

Theme Biobank and collections of Health RI launched a new project to develop a novel Dutch Biobank Standard

30 March 2023

In February 2023 the theme Biobanks and Collections of Health-RI launched a new project entitled: “Dutch biobanking standard: towards harmonized, evidence-based collection, processing and storage of human biomaterials”.

Health-RI receives definitive follow-up funding from the National Growth Fund

30 March 2023

The full funding of a total of 69 million euros has been definitively awarded to Health-RI, the national health data infrastructure for research and innovation.

Control over Human Biomaterials Act [Wet zeggenschap lichaamsmateriaal] (Wzl)

19 July 2022

The Ministry of Health, Welfare and Sport (VWS) is currently preparing a Control over Human Biomaterials Act [Wet zeggenschap lichaamsmateriaal] (Wzl) which will serve in the future as a specific legal framework for the (further) use of body tissue for medical scientific research.